){kind=logo}
FeNO by NIOX®
Stand: A12R
- | Healthcare monitoring / diagnostics
- | Medical devices and supplies
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their next generation product, NIOX PRO®, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma.
NIOX PRO® provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of inflammatory airway conditions like asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary care settings.
The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX® is also committed to offering additional training and support for healthcare professionals.
Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX PRO®, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage inflammatory airway conditions like asthma and COPD.
References:
1. Alving K et al. Pulm Ther. 2017;3:207-218.
2. Gao J et al. Allergy, Asthma & Clinical Immunology. 2018;1
3. Busse WW et al. Lancet Respir Med. 2021;9(10):1165-1173.
4. Menzies-Gow A et al. C Eur Respir J. 2020;55(3):1901633.
5. NIOX®. Data on File; MKT-DOF-007.
Address
Magdalen Centre 1 Robert Robinson Avenue The Oxford Science Park LittlemoreOxford
Oxfordshire
OX4 4GA
United Kingdom
Contact Exhibitor
Products
-
)
Introducing NIOX PRO® - After years of development and customer feedback, the next generation of NIOX® is finally here.
1 Results